Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience. [PDF]
Khavandi MM +11 more
europepmc +1 more source
<sup>99m</sup>Tc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following <sup>90</sup>Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD). [PDF]
Bassir A +8 more
europepmc +1 more source
Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry. [PDF]
Young S +9 more
europepmc +1 more source
Theranostics in Sarcoma: A Critical Review of Current Evidence and Future Potential. [PDF]
Appana O, Konieczkowski D, Tinoco G.
europepmc +1 more source
Development and clinical deployment of an automated planning tool for prostate only and male whole pelvis plans based on multi-criteria optimization. [PDF]
Huang K +5 more
europepmc +1 more source
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma. [PDF]
Núñez K +7 more
europepmc +1 more source
A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis. [PDF]
Yao CY +8 more
europepmc +1 more source
Fast [<sup>177</sup>Lu]Lu-PSMA SPECT/CT with dual-energy acquisition and Monte Carlo-based scatter correction. [PDF]
Könik A +5 more
europepmc +1 more source
Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma. [PDF]
Lin H, Tan Q.
europepmc +1 more source
Radiological Loco-Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature. [PDF]
Pallas D +6 more
europepmc +1 more source

